Singapore, Jan. 30 -- Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirmed its plans to build a state-of-the-art production facility in the Saarland region of southwest Germany.

This strategic investment marks a significant milestone in the company's long-term global growth strategy. Construction is scheduled to begin in the second quarter of 2026. Initially, approximately €480 million have been allocated for the first construction phase of the new commercial production plant. Operations are expected to commence in 2031.

The Contract Development and Manufacturing Organization (CDMO) acquired the approximately 95-acre industrial property in the city of Saarlouis a...